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Abstract:  
Natural selection can promote or hinder a population’s evolvability – the ability to evolve new 
and adaptive phenotypes – but the underlying mechanisms are poorly understood. To examine 
how the strength of selection affects evolvability, we subjected populations of yellow fluorescent 5 
protein to directed evolution under different selection regimes, and then evolved them towards 
the new phenotype of green fluorescence. Populations under strong selection for the yellow 
phenotype evolved the green phenotype most rapidly. They did so by accumulating mutations 
that increase both robustness to mutations and foldability. Under weak selection, 
neofunctionalizing mutations rose to higher frequency at first, but more frequent deleterious 10 
mutations undermined their eventual success. Our experiments show how selection can enhance 
evolvability by enhancing robustness and create the conditions necessary for evolutionary 
success.  
 
 15 
One Sentence Summary: Natural selection drives the evolution of protein evolvability by 
enhancing robustness and foldability.  
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Main Text:  
Natural selection drives adaptation, but we still know little about its role in changing the 
evolvability of a trait or organism (1, 2). On the one hand, strong selection for an ancestral 
phenotype may enhance evolvability for derived phenotypes, because it may favor mutations that 
enhance not just fitness but also evolvability. The available evidence is limited and indirect (3–5 
5). For example, a cytochrome P450 BM3 variant engineered for greater stability and fitness 
buffers the destabilizing effect of mutations that are neofunctionalizing, i.e., that convey new 
protein activities (5, 6).  
On the other hand, strong selection may impair evolvability because it purges weakly deleterious 
mutations that can convey new functions (7). Evolutionary theory holds that selection helps 10 
populations find peaks in adaptive landscapes of fitness, which can be visualized as topological 
maps of peaks and valleys. Weakly deleterious “stepping stone” mutations may help a population 
traverse the valleys that separate different fitness peaks. Such valleys, which are caused by 
epistatic interactions between different mutations, are abundant in the adaptive landscapes of 
evolving proteins (8–11). Weak selection that purges only the most detrimental mutations can aid 15 
such valley-crossing. Consistent with this view, when the enzyme β-lactamase TEM-1 is subject 
to “intense neutral drift” during experimental evolution – multiple rounds of mutation and 
selection to preserve its native phenotype of ampicillin resistance – the evolution of resistance to 
the newly introduced antibiotic cefotaxime is accelerated (3, 12). More generally, experimental 
evolution shows that a population evolves a derived phenotype faster if it harbors genetic 20 
variation in the loci that affect the ancestral phenotype (3, 13, 14). Such standing genetic 
variation may even be adaptive if it has little effect on the ancestral phenotype (15). Therefore, 
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conditionally neutral or weakly deleterious mutations can accelerate the adaptive evolution of a 
derived phenotype (15). Here we performed experiments aimed to find out whether strong or 
weak selection more effectively enhances evolvability. 
Results 
Strong selection leads to greater evolvability than weak or no selection 5 
We evolved yellow fluorescent protein [YFP, a variant of a jellyfish fluorescent protein (16)] in 
E.coli from an ancestral phenotype (yellow fluorescence) to a derived phenotype (green 
fluorescence) (Fig. 1A). The protein was engineered to be well expressed in E.coli (16) but it is 
not native to E.coli, which minimizes interference with the native E.coli proteome. Studying 
evolvability in a single protein can help us analyze the causes of evolvability in molecular detail. 10 
In addition, the fluorescent phenotype permits us to control the strength of selection with 
precision, because fluorescence-activated cell sorting (FACS) can screen individual cells for their 
phenotype.  
We subjected each of four replicate populations of E. coli expressing yellow fluorescent proteins 
to four rounds (‘generations’) of directed evolution. In phase I of our experiment (Fig. 1A), we 15 
selected for yellow fluorescence through either strong selection (populations S, the top ~20% of 
fluorescing cells survive) or weak selection (populations W, cells that fluoresce above 
background survive) (17). We also subjected four replicate populations of yellow fluorescent 
proteins to four rounds of directed evolution without any selection for fluorescence (populations 
N, subject only to neutral drift). After  phase I evolution, we initialized phase II evolution by 20 
subjecting the same populations to another four rounds of directed evolution under selection for 
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green fluorescence (Fig. 1A) (17). We used mutagenic PCR to generate 0.84 amino-acid 
changing mutations per YFP molecule per generation (tables S1 to S3).  
During phase I evolution, yellow fluorescence in the unselected populations N dropped rapidly 
and decreased to <5% of the ancestral YFP’s intensity, indicating an accumulation of deleterious 
mutations (Fig. 1B). For populations under weak selection, W, the intensity of yellow 5 
fluorescence decreased after the first generation of evolution but remained constant in the next 
three generations (Fig. 1B). This suggests a mutation-selection balance between the production 
of new deleterious mutations and selection against such mutations. In contrast, yellow 
fluorescence in populations under strong selection, S, significantly increased by 92.5% after four 
generations of evolution (one-sided t test, P <0.001; Fig. 1B), indicating a likely spread of 10 
beneficial mutations.  
We genotyped ~500 to 1000 protein variants per population and generation (table S4), which 
revealed that our evolving populations harbored different amounts of genetic variation. 
Specifically, during phase I populations W accumulated more amino acid-changing mutations 
and greater genetic diversity than populations S (figs. S1 and S2). Because greater genetic 15 
diversity may facilitate adaptive evolution, we hypothesized that populations W may have greater 
potential than populations S to evolve green fluorescence during phase II evolution. However, 
the opposite was the case. Populations S reached significantly higher green fluorescence than 
populations W during the first two generations of phase II evolution (one-sided Dunnett test with 
single-step adjustment, P<0.05; Fig. 1C). In addition, populations S evolved a green (512 nm) 20 
emission peak more rapidly than populations W (fig. S3). Analogous differences exist between 
populations W and unselected populations N (Fig. 1C, and figs. S1 to S3). In sum, selection on an 
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ancestral phenotype, and in particular strong selection, facilitates the evolution of a derived 
phenotype. 
Strong selection on an ancestral phenotype leads to the most rapid fixation of 
neofunctionalizing mutations  
To find out why strong selection causes greater evolvability than weak selection, we studied the 5 
dynamics of genetic polymorphisms in each replicate population during phase II (fig. S4). Two 
mutations (G66S and Y204C) swept through each replicate S, W and N population. Because of 
their ubiquity, we refer to these two mutations as universal mutations. In addition, another 20 
mutations attained a frequency exceeding 30% in at least one replicate of populations S, W and 
N. To determine whether all these (2+20) mutations are adaptive for green fluorescence, we 10 
engineered each of them into the ancestral YFP and measured their effects on green fluorescence. 
Only the two universal mutations G66S and Y204C caused green shifts of the emission peaks 
(Fig. 2A). Individually, these mutations caused a ~9-fold and ~2-fold increase in green 
fluorescence (fig. S5), and together they shifted the emission peak from yellow (530 nm) to 
green (512 nm; Fig. 2A). Thus, G66S and Y204C are the only neofunctionalizing mutations.  15 
To further characterize the role of the remaining mutations, we engineered each of these 
mutations into the background of G66S+Y204C, referred to as genotype U for ‘universal’, and 
measured the effect of these 20 genotypes on green fluorescence. Nine mutants significantly 
enhanced green fluorescence in the background of U (two-sided Dunnett test with single-step 
adjustment, P<0.001; fig. S5), but none of these changed the emission spectrum (Fig. 2B). These 20 
mutations might increase the amount of soluble and functional fluorescent protein, which may 
help explain why green fluorescence also increased, albeit very modestly, during selection for 
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yellow fluorescence in phase I (Fig. 1B). 
Because only two mutations are responsible for the green shift in phase II, we suspected that the 
rapid spread of these two mutations resulted in faster adaptation of the strong selection (S) 
populations compared to the weak selection (W) and unselected (N) populations. Indeed, 
populations S displayed a higher frequency of the universal mutations G66S andY204C, and of 5 
the universal genotype U in at least last three of the four phase II generations (Fig. 2C).  
Because the S, W, and N populations were subject to identical selection pressures during phase II, 
these faster sweeps likely originated in differences between populations at the end of phase I. We 
investigated if the reason was that the neofunctionalizing mutations had already attained a higher 
frequency in populations S at the end of phase I. However, this was not the case. Both universal 10 
mutations had lower frequency in populations S at the end of phase I evolution, and one of them 
(Y204C) had a significantly lower frequency in populations S than in populations W and N (one-
sided Dunnett test with single-step adjustment, P <0.001; fig. S6).  
Strong selection leads to greater mutational robustness and higher foldability than weak 
selection 15 
To resolve this apparent paradox – faster spreading of the neofunctionalizing mutations G66S 
and Y204C despite their lower initial frequency – it is relevant that our evolving sequences are 
likely to acquire one or more new mutations (with probability 0.53) in every generation (table 
S2). In addition, mutations that are different from the two neofunctionalizing mutation are 
expected to arise by chance alone 412-fold more often than these two mutations (table S2). This 20 
means that most variants containing neofunctionalizing mutations will also accumulate many 
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other mutations, most of which are near-neutral or deleterious (18, 19). Increased robustness to 
such slightly deleterious mutations would increase the fitness of genotypes carrying 
neofunctionalizing mutations, and thus enable their spreading. We thus hypothesized that 
populations S had acquired genetic changes that cause greater robustness to deleterious 
mutations.  5 
To validate this hypothesis, we mutagenized populations S, W and N at the end of phase I, and 
determined the residual fluorescence and the frequency of fluorescence-positive variants after 
mutagenesis. Populations S had indeed acquired greater mutational robustness, in both the 
ancestral yellow phenotype and the derived green phenotype. Specifically, populations S retained 
significantly higher yellow fluorescence intensity than populations W and N after mutagenesis 10 
(two-sided Dunnett test with single-step adjustment, P <0.05 and 0.01 for comparing S with W 
and N; Fig. 3A).  In addition, the post-mutagenesis frequency of yellow-fluorescence positive 
variants in S populations was 1.24-fold and 13.0-fold higher than in W and N populations (Fig. 
3B). Moreover, the post-mutagenesis frequency of high-green variants, which have higher green 
fluorescence than the ancestral YFP, was 3.8-fold and 326.4-fold higher in S populations than in 15 
W and N populations, respectively (Fig. 3B).  
Because most deleterious mutations reduce protein solubility by causing protein misfolding and 
instability (20, 21), we suspected that populations S have evolved the ability to buffer such 
mutations by harboring protein variants with especially high foldability (folding efficiency) or 
stability (the free energy required to unfold a protein). Folding efficiency and stability can be 20 
jointly quantified by the concentrations of soluble protein in vivo (22). We thus measured and 
compared the amount of soluble fluorescent proteins in populations S, W and N at the end of 
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phase I  (17). The amount of soluble proteins in populations S relative to that of ancestral YFP is 
1.9-fold and 3.8-fold higher than that in populations W and N (Fig. 3C). By contrast, the fraction 
of insoluble protein in populations S is 2.8-fold and 2.5-fold lower than that in populations W and 
N (Fig. 3D and fig. S7), respectively.  
We also analyzed the role of foldability more directly by quantifying the refolding yield of 5 
fluorescent proteins after unfolding (17). Indeed, a higher percentage of unfolded fluorescent 
proteins in populations S refolded than in populations W, N and in ancestral YFP during 24 hours 
of refolding (Fig. 3E and fig. S8A). Also, fewer than 50% of unfolded proteins refolded correctly 
at 25 °C within 24 h (Fig. 3E), demonstrating that solubility is likely limited by correct protein 
folding. In addition, the foldability of populations S did not decrease after random mutagenesis, 10 
whereas it decreased in populations W and N (fig. S8B). This observation suggests that increased 
foldability also increases mutational robustness.  
Foldability cannot be completely disentangled from protein stability, because many mutations 
affect both (20, 23).  Stability can be estimated by monitoring a protein’s structural integrity over 
time, and we measured for all our populations the residual yellow fluorescence after 12 h of 15 
incubation at 37 °C, the temperature at which we had conducted our experiments. All 
populations retained more than 95% of yellow fluorescence (fig. S8, C and D). Populations S 
showed higher stability than populations W, N and ancestral YFP only at higher, unphysiological 
temperatures above 65 °C (fig. S8, E and F). In sum, our experiments suggest that the higher 
robustness of populations S is primarily caused by higher foldability.   20 
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Foldability-improving mutations result in greater mutational robustness and higher 
evolvability 
We next aimed to identify the genetic changes that increased foldability and mutational 
robustness by examining our sequence data. We focused on the 2 neofunctionalizing and 20 non-
neofunctionalizing mutations that reached a frequency exceeding 30% at the end of phase II in 5 
populations S, W and N (fig. S4). The best candidates among them are four variants known to 
improve foldability (F47L, F65L, V164A and I172V) (23–25). All of these mutations and a fifth 
one (K102E) reached a higher frequency at the end of phase I in S populations relative to both W 
and N populations (fig. S9).  
When we unfolded these mutants and refolded them (17), all five mutants yielded more correctly 10 
refolded protein than ancestral YFP (Fig. 4A), and three of them also refolded more rapidly than 
ancestral YFP (table S5). In addition, the mutations cause increased protein solubility (figs. S10A 
and S11). Notably, four of them also increased foldability (figs. S10B and table S5) and two of 
them significantly increased solubility in the background U (one-sided Dunnett test with single-
step adjustment, P<0.05; figs. S10 C and S11), which folds with similarly low yield (~ 30%) as 15 
ancestral YFP (fig. S10D and table S5). The mutants also increased thermostability, albeit only at 
unphysiologically high temperatures (fig. S10, E to G, and table S6), indicating that they 
probably do not increase solubility by improving thermostability. In sum, all five key mutations 
improve foldability or protein solubility in the ancestral YFP background, and four of them do so 
in the green fluorescent protein background U. 20 
To estimate the mutational robustness of specific mutants, we used PCR to introduce random 
mutations into ancestral YFP and into each of the 22 high-frequency YFP variants. We then 
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calculated the percentage of fluorescence retained relative to fluorescence before mutagenesis. 
After random mutagenesis, four out of five foldability-improving mutants retained greater yellow 
fluorescence (by 13.3 to 25.2%) than ancestral YFP (Fig. 4B), which indicates that they 
increased robustness. In one of the mutants (K102E), the increase in robustness was marginally 
significant (two-sided Dunnett test with single-step adjustment, P=0.064; Fig. 4B). After random 5 
mutagenesis, none of the other 17 mutations significantly retained greater yellow fluorescence 
intensity than ancestral YFP (two-sided Dunnett test with single-step adjustment, P>0.05; fig. 
S12). In addition, random mutations in all foldability-improving mutants created significantly 
more variants that remained yellow-fluorescence-positive than ancestral YFP (two-sided Dunnett 
test with single-step adjustment, P<0.05; Fig. 4C). Thus, foldability-improving mutations 10 
enhance the mutational robustness of the original yellow-fluorescence phenotype.  
In addition, the five foldability-improving mutants also enhanced the robustness of the derived 
green fluorescence phenotype. First, after mutagenesis they retained significantly higher green 
fluorescence intensity (15.2 to 35.3% higher) than randomly mutated ancestral YFP (two-sided 
Dunnett test with single-step adjustment, P<0.05; Fig. 4B). Second, random mutations in the 15 
foldability-improving mutants created significantly more variants that remained green-
fluorescence-positive (14.6-37.5% more) than ancestral YFP (two-sided Dunnett test with single-
step adjustment, P<0.01; Fig. 4C). In addition, three foldability-improving mutations (F47L, 
F65L and I172V) significantly improved green fluorescence (by more than 27.0%) when 
combined with the two neofunctionalizing mutations (two-sided Dunnett test with single-step 20 
adjustment, P<0.001; fig. S5). These results suggest that the foldability-enhancing mutations can 
accelerate a selective sweep of neofunctionalizing mutants during phase II. In support of this 
observation, the foldability-improving mutations achieved higher frequency in S populations 
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than in W and N populations during each generation of evolution (fig. S13). Moreover, 
populations S retained a greater percentage of cells with higher green fluorescence than the 
ancestor during phase II evolution (Fig. 5A).  
The advantage of the foldability-enhancing mutations could be mainly caused by their effect on 
robustness or by their effect on increasing fluorescence. We distinguished these two possibilities 5 
by measuring the effect of each mutation on fluorescence with or without mutagenesis. For 
example, the mutant F47L alone caused a 1.067-fold increase in green fluorescence-positive cells 
relative to ancestral YFP. After random mutagenesis of the mutant F47L, the increase in green 
fluorescence-positive cells relative to the mutagenized ancestral YFP was 1.390-fold. Thus, 
mutational robustness was responsible for most [84.2 % = 100×(1.390-1.067)/(1.390-1.0)] of the 10 
mutant’s benefit for green fluorescence phenotype. This holds also for the other mutations, where 
we estimate that on average >75% of the fluorescence benefit comes from increased robustness 
(Fig. 5B). Thus, foldability-improving mutations likely promoted the spreading of 
neofunctionalizing mutations by enhancing robustness. This is consistent with the observation 
that the foldability-improving mutations did not greatly increase specific green and yellow 15 
fluorescence on their own (table S7). In the genetic background U, three of these mutations 
(F47L, F65L and I172V) also increased specific green fluorescence by more than 14% (table 
S7), and two of them (F47L and F65L) may have done so because of their spatial proximity to 
the chromophore (fig. S14). Such improvements in specific green fluorescence might 
additionally help promote the fixation of U.  20 
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Selection can eliminate deleterious mutations despite the presence of robustness-enhancing 
mutations   
Although robustness-enhancing mutations augment the advantage of other beneficial mutations, 
their interactions with deleterious mutations are more complex. If they completely mask the 
effects of a deleterious mutation, this mutation may be preserved. However, if the mutation 5 
remains somewhat deleterious even in the presence of robustness-enhancing mutations, it may 
still be eliminated by selection, and at a rate that depends on the strength of selection. To test 
whether selection in S populations was sufficiently strong to eliminate deleterious mutations, we 
first used nonsense mutations, which produce truncated protein isoforms (26). Indeed, the 
frequency of nonsense mutations remained 2.1-fold lower in S than in W populations and 18.7-10 
fold lower than in N populations at the end of phase I (Fig. 5C).  
To complement this analysis, we also used the FoldX algorithm to predict destabilizing 
mutations(17). Such destabilizing mutations too became depleted in S populations (figs. S15 to 
S17). Specifically, highly destabilizing mutations had a consistently lower frequency in S 
populations than in W and N populations throughout phase I evolution (figs. S15A  toS17). At the 15 
end of phase I, this frequency was 2.4-fold and 9.7-fold lower in S populations than in W and N 
populations, respectively (figs. S15A). Also, the protein variants of populations S were on 
average more stable than those of populations W and N during phase I evolution (fig. S15B). 
Because computational stability predictions may be inaccurate when a protein harbors multiple 
amino acid changes (27), we also experimentally measured the stability of fluorescent proteins 20 
expressed in our populations. In these experiments, proteins from S populations showed greater 
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stability at 65 to 80 °C than those from W and N populations (fig. S8E). This prevalence of more 
stable proteins in S populations also persisted after mutagenesis (fig. S8F). In sum, selection can 
purge strongly deleterious mutations even in the presence of robustness-enhancing mutations.  
Robustness-enhancing mutations help increase genetic diversity in populations subject to 
selection 5 
Though not completely preventing the purging of deleterious mutations, robustness-enhancing 
mutations can still increase genetic diversity within a population by helping a population tolerate 
some deleterious mutations. Specifically, we observed that in both S and W (but not N) 
populations, proteins that carried robustness-enhancing mutations also harbored a significantly 
greater number of other amino acid changes at the end of phase I (one-sided t-tests, P<0.05; fig. 10 
S18).   
To further examine whether robustness-enhancing mutations help populations S tolerate 
deleterious mutations during phase II evolution, we focused on the 22 mutations that reached a 
frequency exceeding 30% at the evolutionary end point. Among these mutations we identified 
four strongly deleterious mutations that significantly reduced the fluorescence of the universal 15 
green fluorescent genotype U by more than 20% (E18G, M79L, R110S and N145S; two-sided 
Dunnett test with single-step adjustment, P<0.001; fig. S5). Three of these deleterious mutations 
occurred in populations S, whereas only one of them occurred in any other population. Notably, 
more than 85% of the genetic variants that harbored one of these mutations also harbored at least 
one of the five foldability-improving mutations at the evolutionary end point (fig. S19). This 20 
suggests that robustness-enhancing mutations helped populations S tolerate strongly deleterious 
mutations. It is also consistent with the observation that populations S experienced greater 
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increases in both the number of amino-acid changes and in genetic diversity than populations W 
and N during phase II evolution (Fig. 6, A and 6B). 
Discussion  
Neutral or weakly deleterious mutations can play an important role in adaptive evolution (13, 
28), because they can convey new functions. They also help populations respond rapidly to 5 
environmental changes (3, 7, 12, 13) and traverse fitness valleys created by epistatic (non-
additive) mutational interactions (29). Weak purifying selection facilitates the accumulation of 
such mutations (7). If they were central to the evolution of a derived green fluorescence 
phenotype, our weak selection regime should have resulted in higher evolvability of this 
phenotype. However, we found that strong selection led to a more rapid evolution of the green 10 
fluorescence phenotype (Fig. 1B).  
To understand why, consider that many proteins are marginally foldable (30) and marginally 
stable (31). Also, most mutations accumulated during evolution will further reduce protein 
foldability and stability (20, 32), especially under weak selection (12, 33, 34). To function well, 
most proteins must first fold correctly (high foldability) and maintain structural integrity after 15 
folding (high stability) (35), resulting in selection on the evolution of foldability and stability. As 
a result, strong selection can not only stop the erosion of foldability and stability by purging 
deleterious mutations, it also favors mutations that enhance both properties. This ability is 
especially important during the evolution of new phenotypes, because neofunctionalizing 
mutations usually destabilize proteins and reduce folding efficiency (5, 34, 36). In our 20 
experiments, strong selection favored mutations that increase foldability and, to an even greater 
extent, mutational robustness. In doing so, selection enhanced the penetrance of beneficial 
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mutations (Fig. 5A) and accelerated selective sweeps (Fig. 2C). In addition, foldability-
improving mutations may also promote the fixation of neofunctionalizing mutations by 
improving their specific protein activity during adaptive evolution (table S7). We anticipate that 
our observations apply to the evolution of most proteins in which foldability and stability are 
important.  5 
Our experiments required high mutation rates so that we could observe adaptive evolution on a 
laboratory time scale. Comparable mutation rates have been observed in viruses (37, 38) and 
microbes, especially those that are challenged to evolve rapidly by environmental stressors (39–
42). Such high mutation rates are also required for the evolution of robustness as a direct 
response to mutation pressure (3, 4, 43). However, because our evolvability-enhancing mutations 10 
increase both robustness and foldability (Fig. 6C), their direct fitness benefit (fig. S20) would 
help them accumulate also under much lower mutation rates. An important question is whether 
the advantage of strong selection for evolvability also persists at low mutation rates.  
Our work highlights the important role of standing variation for evolvability (13, 14, 20, 44–46). 
It shows that natural selection can play a crucial and active role in creating standing variation 15 
that is both beneficial and enhances evolvability—for example by increasing robustness to 
deleterious mutations. This contrasts with some theoretical and experimental work, in which 
first-order selection for fitness conflicts with second-order selection for robustness (47, 48). We 
predict that evolution can avoid this conflict when mutations with both fitness-enhancing and 
evolvability-enhancing roles exist.  20 
Our work also suggests experimental designs that select for beneficial mutations without 
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depleting genetic variation before selecting for a new phenotype. Such experiments could be 
further enhanced by starting with protein variants engineered for high robustness. Furthermore, 
our observations extend beyond bioengineering. We expect that the evolutionary rescue of 
populations after environmental challenges, like climate change, may be easier in cases where a 
population’s evolutionary potential has been previously enhanced by strong selection. Most 5 
generally, our observations suggest that natural selection can create favorable conditions for 
Darwinian evolution.   
Materials and methods summary 
Plasmids and Strains 
We used the plasmid vector pBAD202/D-TOPO (K4202-01, Invitrogen) for cloning and 10 
expressing YFP alleles. This vector contains a kanamycin resistance marker and an arabinose-
inducible araBAD promoter. We used E. coli strain BW27783 (CGSC 12119) as a host to enable 
the homogeneous expression of the arabinose-inducible araBAD promoter (49).  
Creating mutant libraries 
We used the same mutagenesis protocol during phase I and phase II of our experiments (17). 15 
Specifically, we performed mutagenic PCR (using the primers MutafpF and MutafpR, table S8) 
to randomly introduce mutations into the coding region of YFP, inserted the resulting mutant 
pool into the vector backbone by ligation, and then electroporated the ligation product into 
electrocompetent cells (17). After electroporation, we immediately added 1 ml of pre-warmed 
SOC medium, incubated the recovering cell culture for 1.5 h at 37 °C with shaking at 220 rpm in 20 
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a 50 ml tube, and used the recovered culture for further experiments.  
To avoid the accumulation of mutations in the plasmid outside the YFP coding region, we 
inserted randomly mutated YFP genes into a fresh plasmid backbone in each generation. In 
addition, to avoid mutations that might accumulate in the E.coli genome, we transformed 
mutated YFP gene pools into fresh E.coli competent cells in each generation. 5 
Directed evolution  
We induced fluorescent protein expression in evolving populations at 37 °C for 12 h (with 
shaking at 220 rpm) by using 0.2% arabinose (17). We used an Aria III cell sorter (BD 
Biosciences) to sort cells at 4 °C in the fluorescein isothiocyanate (FITC) channel (λex = 488 nm, 
λem = 530 ± 15 nm; phase I evolution) or in the AmCyan channel (λex = 405 nm, λem = 525 ± 25 10 
nm; phase II evolution) according to the selection criteria described in Fig.1. In phase I 
evolution, we collected ~106 selected cells in ~1 ml of cold phosphate-buffered saline (PBS) 
buffer at 4 °C for each replicate population (17). In phase II evolution, we first selected ~5×104 
cells with the top 1% of green fluorescence intensity, re-grew the sorted cells, and repeated the 
sorting process by again selecting ~104 cells in the top 1% of green fluorescence intensity (17). 15 
In each round, we regrew sorted cells, and isolated plasmids from sorted cells and used them as 
templates for the next mutation-selection cycle and for single-molecule real-time (SMRT) 
sequencing (17). To prevent cell proliferation or death, we placed selected cells on ice before the 
subsequent steps.  
Engineering YFP variants 20 
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We used whole-plasmid PCR to engineer single mutants and some double mutants by designing 
primers that carry the corresponding mutations (table S9) (17). We also used whole-plasmid PCR 
to engineer single mutations into the genetic backgrounds of G66S, Y204C or U (G66T+Y204C) 
by using the mutants G66S, Y204C or U as templates (17). We used Gibson Assembly Master 
Mix (E2611, NEB) to engineer the double mutant U (G66T+Y204C) by using the primers 5 
G66Sf/Y204Cr and Y204Cr/G66Sf (table S9) (17).  
Fluorescence assay using flow cytometry  
We grew evolving populations or engineered variants in 200 μl or 2 ml of LB with 0.2% 
arabinose to induce the expression of YFP variants in evolving populations or engineered YFP 
variants (17). We added 40 μl of a culture to 160 μl of cold PBS buffer, transferred 20 μl of the 10 
resulting suspension to 180 μl of cold PBS buffer, and mixed the solution thoroughly. We used 
the resulting mixture to measure yellow fluorescence (λex = 488 nm and λem = 530 ± 15 nm) and 
green fluorescence (λex = 405 nm and λem = 525 ± 25 nm) using flow cytometry. We performed 
fluorescence assays at room temperature with a flow rate of ~3000 events/s by using a Fortessa 
cell analyzer (BD Biosciences). We performed at least three biological replicates for each 15 
replicate population or each variant, and analyzed ~104 events per replicate. To prevent cell 
proliferation or death, we placed all samples on ice until we had finished all assays. 
Flow cytometry data analysis 
We performed flow cytometry data analysis by using FlowJo V10.4.2 (LLC). Briefly, we used 
forward scatter height (FSC-H) versus side scatter height (SSC-H) density plots to select a 20 
homogeneous cell population (p1 in fig. S21A), and used side scatter area (SSC-A) versus side 
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scatter height (SSC-H) density plots to exclude doublets (p2 in fig. S21B). We used the resulting 
filtered data p2 for determining the fluorescence intensity of evolving populations, and for 
determining mutational robustness of evolving populations and those single mutants (Figs. 1, 3, 
4, and 5 and fig. S12). We used FITC-height versus AmCyan-height density plots to select the 
dominant cell population (p3 in fig. S21C), and used the resulting filtered data p3 for 5 
determining the fluorescence intensity of each mutant (figs. S5 and S20). 
Protein solubility determination and refolding kinetics measurements 
We induced the expression of YFP variants in evolving populations or engineered mutants by 
growing cells in 2 ml LB medium with 50 μg/ml of kanamycin and 0.2% arabinose in a 10 ml 
tube at 37 °C and at 220 rpm for 12 h (17). We used CelLytic™ B Cell Lysis Reagent (B7435-10 
500ml, Sigma) to extract both soluble and insoluble proteins from the collected cells by 
following the manufacturer’s protocol (17). We quantified the amount of both soluble and 
insoluble proteins in each sample by SDS–polyacrylamide gel electrophoresis (SDS-PAGE) (17). 
To unfold proteins, we diluted 5 μl of crude lysate with 45 μl of 9M urea (containing 10 mM 
dithiothreitol) and incubated the solution at 95 °C for 5 min. To refold unfolded proteins, we 15 
diluted 10 μl of the unfolded samples with 180 μl of TNG buffer in a 96 well microplate, and 
used an infinite F200 Pro (λex = 485 nm, λem = 530 nm) or a Spark 10M (λex = 485 nm, λem = 
530 nm and λex = 405 nm, λem = 512 nm) microplate reader to measure fluorescence intensity at 
~20min intervals (17).  
SMRT sequencing and sequence data analysis 20 
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We barcoded YFP variants of each replicate population by using PCR and ligation for SMRT 
sequencing and used the Pacific Biosciences RS2 instrument (Pacific Biosciences) to perform 
sequencing (17). We used the SMRTAnalysis v2.3 package (50) to perform primary data analysis 
(17). We wrote Python scripts (Python 2.7.12) to identify point mutations and their combinations, 
and to calculate genetic diversity in each replicate population from each generation of evolution 5 
(17). 
Statistical analysis 
Unless specified otherwise, we conducted pairwise comparisons by using a one-tailed t-test, and 
conducted multiple comparisons to a control by using a one-sided Dunnett test with single-step 
adjustment. We performed all statistical analysis using R version 3.4.1. 10 
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Legends 
Fig. 1. Experimental evolution of yellow fluorescent protein. (A) We subjected four replicate E. coli 
populations for each experimental treatment to directed evolution under selection for yellow fluorescence 
(phase I, λex = 488 nm and λem = 530 ± 15 nm). After four mutation-selection cycles, we continued 
directed evolution for four more cycles but under selection for green fluorescence (phase II, λex = 405 nm 5 
and λem = 525 ± 25 nm) by selecting the top 0.01% of cells in each generation. The areas shaded in 
yellow or green indicate the proportion of a population allowed to survive to the next generation. (B and 
C) Fold-change of yellow (dashed lines) and green (solid lines) fluorescence intensity relative to ancestral 
YFP in each generation of phase I (B) and II (C). Error bars represent 1 SEM, from four replicate 
populations (single small symbols). *P <0.05; **P <0.01; ***P <0.001 [one-sided Dunnett tests with 10 
single-step adjustment to compare S with W (blue) or N (black)]. 
Fig. 2. Most rapid fixation of neofunctionalizing mutations after strong selection on the ancestral 
phenotype. (A and B) Emission spectra at the new excitation wavelength (405 nm) of mutants introduced 
into ancestral YFP (A) and U (B). The vertical axes indicate the fold-change of green fluorescence 
intensity relative to ancestral YFP at a given emission wavelength (horizontal axes). Each curved line 15 
represents the emission spectrum of 1 of the 44 mutants (n = 3). Colored lines in panel A indicate those 
emission-shifted mutations, and colored lines in panel B indicate mutations that significantly improved 
green fluorescence in the genetic background U (two-sided Dunnett test with single-step adjustment, 
P<0.05; fig. S5). Yellow and green vertical dashed lines indicate 530 nm (λex = 485 nm) and 512 nm (λex 
= 405 nm). (C) Frequencies of neofunctionalizing mutations G66S and Y204C or the double mutant U 20 
during evolution. Error bars represent 1 SEM from four replicate populations. *P <0.05; **P <0.01; ***P 
<0.001 [one-sided Dunnett tests with single-step adjustment to compare S with W (blue) or N (black)]. 
Abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; E, Glu; F, Phe; G, Gly; I, Ile; K, 
Lys; L, Leu; M, Met; S, Ser; V, Val; and Y, Tyr. 
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Fig. 3. Strong selection leads to greater mutational robustness and higher foldability than weak 
selection. (A) Yellow fluorescence retained by each population at the end of phase I after mutagenesis 
relative to its yellow fluorescence without mutagenesis. (B) Frequencies of cells fluorescing above 
background in yellow (left) (17) or above ancestral YFP (Anc) in green (right) (17) from each population 
at the end of phase I after mutagenesis. (C and D) Amount of soluble protein relative to ancestral YFP 
(C), and insoluble protein fraction (D) in each population at the end of phase I. (E) Recovery of yellow 
fluorescence over time (horizontal axis) during refolding of unfolded fluorescent proteins at 25 °C (17). 
Error bars represent 1 SEM based on four replicate populations. *P <0.05; **P <0.01; ***P <0.001 (two-
sided Dunnett tests with single-step adjustment to compare S with W, N or ancestral YFP). 
Fig. 4. Foldability-improving mutations enhance mutational robustness. (A) Recovery of yellow 
fluorescence during refolding of unfolded ancestral YFP and of the indicated variants at 25 °C (17). (B) 
Fluorescence intensity retained relative to fluorescence without mutagenesis (17). (C) Frequencies of 
fluorescence-positive cells after random mutagenesis (17). Error bars represent 1 SD (n=3). *P <0.05; 
**P <0.01; ***P <0.001 [two-sided Dunnett tests with single-step adjustment to compare each variant 
with ancestral YFP in (B) and (C)]. 
Fig. 5. Enhanced mutational robustness promotes sweeps of adaptive mutations. (A) Percentage of 
cells with higher green fluorescence than ancestral YFP in populations S, W, and N after mutagenesis 
during each generation of evolution (17). (B) Increased mutational robustness (purple) rather than 
fluorescence increase (orange) is the major contributor to the acceleration of green fluorescence evolution 
by foldability-increasing mutations. (C) Strong selection purges nonsense mutations most efficiently 
during phase I evolution. Error bars represent 1 SEM from four replicate populations (A and C), or 1 SD 
over three biological replicates (B). *P <0.05; **P <0.01; ***P <0.001 [one-sided Dunnett tests with 
single-step adjustment to compare S with W (blue) or N (black)].  
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Fig. 6. Mutational robustness helps increase genetic diversity and evolvability. (A) Increase in the 
average number of amino acid changing mutations per fluorescent protein molecule relative to the 
beginning of phase II for evolving populations S, W and N. (B) Increase in genetic diversity relative to the 
beginning of phase II for evolving populations S, W and N. The data show the increase in the number of 
amino acid changing mutations (A) or in genetic diversity (B) in populations S, W and N at the end of 
phase II, relative to the end of phase I. Error bars represent 1 SEM from four replicate populations. *P 
<0.05; **P <0.01; ***P <0.001 [one-sided Dunnett tests with single-step adjustment to compare S with W 
(blue) or N (black)]. (C) Robustness-enhancing mutations can help evolving populations by-pass fitness 
valleys in an adaptive landscape. Robustness-enhancing mutations (short red arrow) can help move a 
population to a region of an adaptive landscape with low curvature, from where an adaptive peak can be 
reached more easily (long red arrow) than without robustness-enhancing mutations (blue arrow). Strong 
selection can help increase the frequency of robustness-enhancing mutations, and more so if such 
mutations also enhance fitness. 
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